These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9702495)

  • 1. Detection of numerical chromosome 17 abnormalities in fine-needle aspirates of breast cancer using a novel in situ hybridization signal amplification method.
    Schmitt FC; Soares R; Leitão D
    Diagn Cytopathol; 1998 Aug; 19(2):141-6. PubMed ID: 9702495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ hybridization of chromosome 6 on fine-needle aspirates from breast carcinomas: comparison of numerical abnormalities and ER/PgR status and staining pattern.
    Sauer T; Beraki K; Jebsen PW; Ormerod E; Naess O
    Diagn Cytopathol; 1997 May; 16(5):420-4. PubMed ID: 9143843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Numerical aberrations of chromosome 17 in interphase cell nuclei of breast carcinoma cells: lack of correlation with abnormal expression of p53, neu and nm23 protein.
    Sauer T; Beraki K; Jebsen PW; Ormerod E; Naess O
    APMIS; 1998 Oct; 106(10):921-7. PubMed ID: 9833692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry.
    Salido M; Tusquets I; Corominas JM; Suarez M; Espinet B; Corzo C; Bellet M; Fabregat X; Serrano S; Solé F
    Breast Cancer Res; 2005; 7(2):R267-73. PubMed ID: 15743507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence in situ hybridisation detection of erbB2 amplification in breast cancer fine needle aspirates.
    McManus DT; Patterson AH; Maxwell P; Humphreys MW; Anderson NH
    Mol Pathol; 1999 Apr; 52(2):75-7. PubMed ID: 10474685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of HER2 gene status in breast cancer with HER2 protein overexpression].
    Zeng X; Liang ZY; Wu SF; Zhou WX; Gao J; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):584-8. PubMed ID: 17134563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating loss of the wild-type p53 gene by in situ hybridization of fine-needle aspirates from breast carcinomas.
    Sauer T; Beraki K; Furu I; Ormerod E; Jebsen PW; Naess O
    Diagn Cytopathol; 1999 May; 20(5):266-70. PubMed ID: 10319226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma.
    Zhao J; Wu R; Au A; Marquez A; Yu Y; Shi Z
    Mod Pathol; 2002 Jun; 15(6):657-65. PubMed ID: 12065780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-erbB2/neu gene and chromosome 17 analysis in breast cancer by FISH on archival cytological fine-needle aspirates.
    Mezzelani A; Alasio L; Bartoli C; Bonora MG; Pierotti MA; Rilke F; Pilotti S
    Br J Cancer; 1999 May; 80(3-4):519-25. PubMed ID: 10408862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA in situ hybridization (interphase cytogenetics) versus comparative genomic hybridization (CGH) in human cancer: detection of numerical and structural chromosome aberrations.
    Van Dekken H; Krijtenburg PJ; Alers JC
    Acta Histochem; 2000 Feb; 102(1):85-94. PubMed ID: 10726167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interphase cytogenetic analysis of erbB2 and topoII alpha co-amplification in invasive breast cancer and polysomy of chromosome 17 in ductal carcinoma in situ.
    Murphy DS; McHardy P; Coutts J; Mallon EA; George WD; Kaye SB; Brown R; Keith WN
    Int J Cancer; 1995 Feb; 64(1):18-26. PubMed ID: 7665243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome 17 aneusomy is associated with poor prognostic factors in invasive breast carcinoma.
    Watters AD; Going JJ; Cooke TG; Bartlett JM
    Breast Cancer Res Treat; 2003 Jan; 77(2):109-14. PubMed ID: 12602909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of the Her-2/neu gene amplification status in cytologic breast cancer specimens using automated silver-enhanced in-situ hybridization (SISH).
    Fritzsche FR; Bode PK; Moch H; Kristiansen G; Varga Z; Bode B
    Am J Surg Pathol; 2010 Aug; 34(8):1180-5. PubMed ID: 20661016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of numerical chromosomal aberrations in hematopoietic malignancy by in situ hybridization on bone marrow aspirate paraffin sections].
    Okada T; Noriki S; Maekawa H; Mori M; Torii K; Ichikawa M; Gejyo F
    Rinsho Byori; 1996 Dec; 44(12):1175-82. PubMed ID: 8990937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of chromosome 17 polysomy in breast cancer: analysis by CEP17 chromogenic in situ hybridization and multiplex ligation-dependent probe amplification.
    Moelans CB; de Weger RA; van Diest PJ
    Breast Cancer Res Treat; 2010 Feb; 120(1):1-7. PubMed ID: 19760503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of automated silver-enhanced in situ hybridization (SISH) for detection of HER2 gene amplification in breast carcinoma excision and core biopsy specimens.
    Shousha S; Peston D; Amo-Takyi B; Morgan M; Jasani B
    Histopathology; 2009 Jan; 54(2):248-53. PubMed ID: 19207950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel in situ hybridization signal amplification method based on the deposition of biotinylated tyramine.
    Kerstens HM; Poddighe PJ; Hanselaar AG
    J Histochem Cytochem; 1995 Apr; 43(4):347-52. PubMed ID: 7897179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Numerical abnormalities of chromosome 7 in interphase cell nuclei of breast carcinoma have no impact on immunohistochemically determined EGFR status.
    Sauer T; Beraki K; Jebsen PW; Naess O
    APMIS; 1999 Feb; 107(2):211-6. PubMed ID: 10225319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical role of HER2 gene amplification and chromosome 17: a study on 154 IHC-equivocal cases of invasive breast carcinoma patients.
    Afzal M; Amir M; Hassan MJ; Hussain MS; Aziz MN; Murad S; Murtaza I; Anees M; Sultan A
    Tumour Biol; 2016 Jul; 37(7):8665-72. PubMed ID: 26738861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aneusomy 17 in breast cancer: its role in HER-2/neu protein expression and implication for clinical assessment of HER-2/neu status.
    Wang S; Hossein Saboorian M; Frenkel EP; Haley BB; Siddiqui MT; Gokaslan S; Hynan L; Ashfaq R
    Mod Pathol; 2002 Feb; 15(2):137-45. PubMed ID: 11850542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.